We develop complex dosage forms enabling Early Market Entry Generic Drugs and innovative SuperGeneric products.We deal with licensing-out to leading Pharma partners worldwide for market access.
Incorporated in September 2015.
Our mission is:
API supply secured mainly (but not only) from Cerbios-Pharma, leveraging sister company long-term expertise in the development and production of drug substances with strong focus on innovation and IP generation.
Licensing-In (Partial)
Licensing-Out
Development
Co-development
Drug Product CMO
Drug development
Drug commercialization
Respiratory
CH
EU Top 5
Rest of Europe
USA and Canada
Japan
LATAM
MENA
BRICS
ASEAN
Australia
Other market
Pre-clinical
Clinical Phase I/Phase III
Phase I - Phase III
Registration
Market
Generic Plus (505B2)
Generic
Life cycle management
Aerosol
Inhaler
Spray
Swissmedic
GMP
ISO 13485
